Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac Westwood

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|April 13, 2007
Arylamine N-acetyltransferasesEdith Sim, Isaac Westwood, Elizabeth Fullam
Protein & Cell|January 5, 2011
Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductasesAli Ryan, Chan-Ju Wang, Nicola Laurieri, et al.
The Protein Journal|July 29, 2009
Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosisElizabeth Fullam, Akane Kawamura, Helen Wilkinson, et al.
Journal of the Royal Society, Interface|July 10, 2009
Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferasesPedro J Ballester, Isaac Westwood, Nicola Laurieri, et al.
Journal of Molecular Biology|April 27, 2010
A novel mechanism for azoreductionAli Ryan, Nicola Laurieri, Isaac Westwood, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|January 9, 2010
Role of tyrosine 131 in the active site of paAzoR1, an azoreductase with specificity for the inflammatory bowel disease prodrug balsalazideChan-Ju Wang, Nicola Laurieri, Areej Abuhammad, et al.
Toxicology|October 15, 2008
Arylamine N-acetyltransferases: structural and functional implications of polymorphismsEdith Sim, Nathan Lack, Chan-Ju Wang, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2013
Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferaseElizabeth Fullam, James Talbot, Areej Abuhammed, et al.
Biochemical Pharmacology|February 19, 2008
Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1Akane Kawamura, Isaac Westwood, Larissa Wakefield, et al.
Cell Cycle (Georgetown, Tex.)|April 8, 2010
Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?Marissa V Powers, Keith Jones, Caterina Barillari, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Metabolism & Toxicology|April 13, 2007
Arylamine N-acetyltransferasesEdith Sim, Isaac Westwood, Elizabeth Fullam
Protein & Cell|January 5, 2011
Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductasesAli Ryan, Chan-Ju Wang, Nicola Laurieri, et al.
The Protein Journal|July 29, 2009
Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosisElizabeth Fullam, Akane Kawamura, Helen Wilkinson, et al.
Journal of the Royal Society, Interface|July 10, 2009
Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferasesPedro J Ballester, Isaac Westwood, Nicola Laurieri, et al.
Journal of Molecular Biology|April 27, 2010
A novel mechanism for azoreductionAli Ryan, Nicola Laurieri, Isaac Westwood, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|January 9, 2010
Role of tyrosine 131 in the active site of paAzoR1, an azoreductase with specificity for the inflammatory bowel disease prodrug balsalazideChan-Ju Wang, Nicola Laurieri, Areej Abuhammad, et al.
Toxicology|October 15, 2008
Arylamine N-acetyltransferases: structural and functional implications of polymorphismsEdith Sim, Nathan Lack, Chan-Ju Wang, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2013
Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferaseElizabeth Fullam, James Talbot, Areej Abuhammed, et al.
Biochemical Pharmacology|February 19, 2008
Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1Akane Kawamura, Isaac Westwood, Larissa Wakefield, et al.
Cell Cycle (Georgetown, Tex.)|April 8, 2010
Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?Marissa V Powers, Keith Jones, Caterina Barillari, et al.
Pageof 2